Dishman Carbogen Amcis Limited

BSE:540701 Stock Report

Market Cap: ₹44.9b

Dishman Carbogen Amcis Past Earnings Performance

Past criteria checks 0/6

Dishman Carbogen Amcis's earnings have been declining at an average annual rate of -60.7%, while the Life Sciences industry saw earnings growing at 25.2% annually. Revenues have been growing at an average rate of 6.2% per year.

Key information

-60.7%

Earnings growth rate

-60.5%

EPS growth rate

Life Sciences Industry Growth11.2%
Revenue growth rate6.2%
Return on equity-3.0%
Net Margin-6.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Dishman Carbogen Amcis makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:540701 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2426,186-1,74012,7450
30 Jun 2424,162-2,48012,2990
31 Mar 2426,158-1,53412,1610
31 Dec 2325,796-1,54211,5100
30 Sep 2325,683-47711,1470
30 Jun 2325,957-16810,7520
31 Mar 2324,129-29810,3820
31 Dec 2223,634-3710,4520
30 Sep 2222,856-15210,3000
30 Jun 2221,306609,9880
31 Mar 2221,4071809,8890
31 Dec 2121,013-7249,5800
30 Sep 2120,078-1,2399,2730
30 Jun 2119,884-1,2779,0720
31 Mar 2119,120-1,6518,8220
31 Dec 2018,9464198,6400
30 Sep 2019,6839088,3220
30 Jun 2019,9611,2467,9240
31 Mar 2020,4361,5857,7200
31 Dec 1921,8121,8378,2280
30 Sep 1921,1792,0228,0860
30 Jun 1920,9832,0507,3610
31 Mar 1920,5862,1037,7180
31 Dec 1818,9241,8627,3310
30 Sep 1818,7451,7687,1320
30 Jun 1818,8261,8126,5410
31 Mar 1816,9481,5466,7660
31 Dec 1717,8541,5376,8440
30 Sep 1716,8401,3836,5680
30 Jun 1716,7781,2825,9440
31 Mar 1717,1941,4546,4960
31 Dec 1612,0389534,240-35
31 Mar 16689510
31 Mar 150-500

Quality Earnings: 540701 is currently unprofitable.

Growing Profit Margin: 540701 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 540701 is unprofitable, and losses have increased over the past 5 years at a rate of 60.7% per year.

Accelerating Growth: Unable to compare 540701's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 540701 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (37.9%).

Return on Equity

High ROE: 540701 has a negative Return on Equity (-3.03%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/17 05:28
End of Day Share Price 2024/12/17 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dishman Carbogen Amcis Limited is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shikha JainAnand Rathi Shares and Stock Brokers Limited
Nikhil ShettyBP Wealth Management Private Limited
Nitin AgarwalDAM Capital Advisors